Leading positive review, I can't live without this stuff nowadays, Reviewed in the United States on November 25, 2018UPDATE: My baby woke up TODAY, with a cough and runny nose and was really weezy. I offered him 6 sprays plus a dropper of wild cherry bark and you would never ever understand he was ill today! Wahoooo! Thanks for making this product.
It is also terrific for autoimmune conditions, where numerous "immune sprays" or other types of boosters in fact make the autoimmune conditions get worse. This is the genuine deal. blood vessels. Oh yeah, and the reduced the cost, duh. Get some! The cash I saved by not missing work is worth it alone.
I have been utilizing nano-ojas with him along with a couple other supplements. His digestion is significantly enhanced, his skin reactions are soothed, his discomfort is gone (at the minute and for a few weeks now), and his tongue, which was becoming geographic and a bit frightening, is pink and back to typical.
That 5mg is about a million times more effective than the more affordable, greater number. Trust me, Policosinol that is not nano is not even worth buying or attempting.
Nano - ojas, nevertheless is like a different animal completely. It took me about 3 weeks to actually see the results and stop believing it was a coincidence every time something recovered extremely fast.
Grownups 18+: 3-5 sprays in mouth once a day, Ages 6-17: 2-3 sprays in mouth once a day, Ages 0-5: 1-2 sprays in mouth when a day.
K.R. I can't thank you enough for presenting me to NANO SOMA! It is a God-sent true blessing that has assisted. I consulted with an Orthopedic cosmetic surgeon whose expertise remained in Hand & Upper extremity in March, 2012, when my Trigger Thumb concern started first. He administered a corticosteroid injection into the tendon sheath to deal with the thumb.
A year later on, the trigger thumb condition returned, and this time I consulted with a different hand expert because we had transferred to our current house in between - medical condition. Once again in July, 2013, I was offered a corticosteroid injection for dealing with the trigger thumb, with the exact same result as prior to - very bad discomfort that lasted for about 4 days however the trigger thumb ended up being alright.
On my last go to, I found out that typically they deal with trigger finger with corticosteroid injection 3 times, and if it returned again, surgery would be the next action. By the fall of 2015, the trigger thumb returned again - long-chain alcohols.
If I knit for a long time, or type a lot, it flares up a little once again, however I am confident that continued usage of NANO SOMA will totally heal it, provided the considerable enhancement I have experienced in my left hand so far! No pain with no side effect is impossible to beat! Thank you very much once again for presenting me to this wonder spray!.
Kassis, A. N. and Jones, P. J. Modifications in cholesterol kinetics following sugar walking cane policosanol supplements: a randomized control trial. View abstract. View abstract. medical doctors.
Long-lasting results of nutraceuticals (berberine, red yeast rice, policosanol) in senior hypercholesterolemic patients. Adv. Ther 2011; 28( 12 ):1105 -1113. View abstract. Mas, R., Castano, G., Fernandez, J., Gamez, R. R., Illnait, J., Fernandez, L., Lopez, E., Mesa, M., Alvarez, E., and Mendoza, S. Long- term effects of policosanol on older patients with Type 2 diabetes.
J Clin Nutr. View abstract. Menendez, R., Mas, R., Amor, A. M., Gonzalez, R. M., Fernandez, J. C., Rodeiro, I., Zayas, M., and Jimenez, S. Impacts of policosanol treatment on the vulnerability of low density lipoprotein (LDL) separated from healthy volunteers to oxidative adjustment in vitro.
View abstract. Mesa, A. R., Mas, R., Noa, M., Hernandez, C., Rodeiro, I., Gamez, R., Garcia, M., Capote, A., and Aleman, C. L. Toxicity of policosanol in beagle pets: 1 year study. Toxicol. Lett. 1994; 73( 2 ):81 -90. View abstract. Mirkin, A., Mas, R., Martinto, M., Boccanera, R., Robertis, A., Poudes, R., Fuster, A., Lastreto, E., Yanez, M., Irico, G - trigger thumb., Mc, Cook, B., and Farre, A.
Int. J.Clin. Pharmacol. Res. 2001; 21( 1 ):31 -41. View abstract. Pisciotta, L., Bellocchio, A., and Bertolini, S. Nutraceutical pill including berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in clients with familial hypercholesterolemia on stable cholesterol-lowering treatment. Lipids Health Dis 2012; 11:123. View abstract. Prat, H., Roman, O., and Pino, E.
Rev. Med. Chil. 1999; 127( 3 ):286 -294 (dr. raghavan). View abstract. Reiner, Z. and Tedeschi-Reiner, E. Rice policosanol does not have any impacts on blood coagulation elements in hypercholesterolemic patients. Coll. Antropol. 2007; 31( 4 ):1061 -1064. View abstract. Rodriguez-Echenique, C., Mesa, R., Mas, R., Noa, M., Menendez, R., Gonzalez, R. M., Amor, A. M., Fraga, V., Sotolongo, V., and Laguna, A.
Food Chem. Toxicol. 1994; 32( 6 ):565 -575. View abstract. Tedeschi-Reiner, E., Reiner, Z., Romic, Z., and Ivankovic, D. [A randomized, double-blind, placebo-controlled research study of the antilipemic efficacy and tolerability of food supplement policosanol in patients with moderate hypercholesterolemia] Lijec. Vjesn. 2005; 127( 11-12):273 -279. View abstract. Abdul MI, Jiang X, Williams KM, et al. Pharmacokinetic and pharmacodynamic interactions of echinacea and policosanol with warfarin in healthy subjects.
Pharmacol. 2010; 69:508 -15. View abstract. Arruzazabala ML, Mas R, Molina V, et al. Impact of policosanol on platelet aggregation in type II hypercholesterolemic patients. Int J Tissue React 1998; 20:119 -24. View abstract. Arruzazabala ML, Molina V, Mas R, et al. Antiplatelet results of policosanol (20 and 40 mg/day) in healthy volunteers and dyslipidaemic patients.
Exp. Pharmacol. Physiol 2002; 29:891 -897. View abstract. Fontani, G., Maffei, D., and Lodi, L. Policosanol, response time and event-related capacities. Neuropsychobiology 2000; 41( 3 ):158 -165. View abstract. Gamez, R., Aleman, C. L., Mas, R., Noa, M., Rodeiro, I., Garcia, H., Hernandez, C., Menendez, R., and Aguilar, C. A 6-Month Study on the Toxicity of High Doses of Policosanol Orally Administered to Sprague-Dawley Rats.
View abstract. Illnait, J., Castano, G., Alvarez, E., Fernandez, L., Mas, R., Mendoza, S., and Gamez, R. Effects of policosanol (10 mg/d) versus aspirin (100 mg/d) in clients with intermittent claudication: a 10-week, randomized, comparative study. Angiology 2008; 59( 3 ):269 -277. View abstract. Janikula, M. Policosanol: a brand-new treatment for cardiovascular disease? Altern.
View abstract. View abstract. View abstract.
Arruzazabala, M. L., Noa, M., Menendez, R., Mas, R., Carbajal, D., Valdes, S., and Molina, V. Protective result of policosanol on atherosclerotic lesions in rabbits with exogenous hypercholesterolemia. Braz. J Med Biol. Res 2000; 33( 7 ):835 -840. View abstract. Carlomagno, G., Pirozzi, C - immune system., Mercurio, V., Ruvolo, A., and Fazio, S. Results of a nutraceutical combination on left ventricular renovation and vasoreactivity in subjects with the metabolic syndrome.
View abstract. View abstract. Castano, G., Mas, R., Fernandez, L., Gamez, R., and Illnait, J. Effects of policosanol and lovastatin in clients with periodic claudication: a double-blind comparative pilot research study - many foods.
View abstract. Castano, G., Mas, R., Gamez, R., Fernandez, L., and Illnait, J. Impacts of policosanol and ticlopidine in patients with periodic claudication: a double-blinded pilot relative research study. Angiology 2004; 55( 4 ):361 -371. View abstract. Cholesterol-lowering action of policosanol compares well to that of pravastatin and lovastatin. Cardiovasc. J.S.Afr. 2003; 14( 3 ):161. View abstract - dietary supplement. Arruzazabala ML, Valdes S, Mas R, et al.
Pharmacol Res 1997; 36:293 -7. View abstract. Arruzazabala ML, Valdes S, Mas R, et al. Effect of policosanol succeeding dose increases on platelet aggregation in healthy volunteers. Pharmacol Res 1996; 34:181 -5. View abstract. Barrat E, Zar Y, Ogier N, et al. A combined natural supplement decreases LDL cholesterol in topics with moderate neglected hypercholesterolemia: a randomized placebo-controlled trial.
2013; 64( 7 ):882 -9. View abstract. Barrat E, Zar Y, Sirvent P, et al. Result on LDL-cholesterol of a big dose of a dietary supplement with plant extracts in topics with unattended moderate hypercholesterolaemia: a randomised, double-blind, placebo-controlled study. Eur J Nutr. 2013; 52( 8 ):1843 -52. View abstract. Batista J, Stusser R, Saez F, Perez B.
View abstract. Effect of policosanol on lipid levels amongst patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial. View abstract.
View abstract. View abstract. Carbajal D, Arruzazabala ML, Valdes S, Mas R. Impact of policosanol on platelet aggregation and serum levels of arachidonic acid metabolites in healthy volunteers.
View abstract. Castano G, Canetti M, Moreira M, et al (customer service). Effectiveness and tolerability of policosanol in elderly clients with type II hypercholesterolemia: A 12-month study. Curr Ther Res 1995; 56:819 -23. Castano G, Fernandez L, Mas R, et al. Contrast of the effectiveness, security and tolerability of original policosanol versus other mixes of greater aliphatic primary alcohols in clients with type II hypercholesterolemia.
J.Clin. Pharmacol. Res. 2002; 22:55 -66. View abstract. Castano G, Fernandez L, Mas R, et al. Impacts of addition of policosanol to omega-3 fat therapy on the lipid profile of patients with type II hypercholesterolaemia. Drugs R.D 2005; 6:207 -219. View abstract. Castao G, Fernndez L, Mas R, Illnait J, Mesa M, Fernndez JC.
Clin Drug Investig. 2003; 23( 10 ):639 -50. View abstract. Castano G, Mas R, Arruzazabala ML, et al. Impacts of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients. Int. J.Clin. Pharmacol. Res. 1999; 19:105 -116. View abstract. Castano G, Mas R, Fernandez JC, et al. Effects of policosanol in older patients with type II hypercholesterolemia and high coronary risk.